Predicting the severity of acute bronchiolitis in infants: Should we use a clinical score or a biomarker?

Journal of Medical Virology

Volumn 86, Issue 11, 2014, Pages 1944-1952

  Amat, Flore ^a   Henquell, Cécile ^b   Verdan, Matthieu ^a   Roszyk, Laurence ^b   Mulliez, Aurélien ^a,b   Labbé, André ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Acute bronchiolitis; Children; Clinical score; KL 6; Severity prediction

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; KREBS VON DEN LUNGEN 6 ANTIGEN; OXYGEN; UNCLASSIFIED DRUG; MUC1 PROTEIN, HUMAN; MUCIN 1;

ACUTE BRONCHIOLITIS; ARTICLE; BREATHING RATE; BRONCHIOLITIS; CHILDHOOD DISEASE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY WARD; EPIDEMIC; FEMALE; FRANCE; HUMAN; HUMAN RHINOVIRUS; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNGEAL ASPIRATION; OXYGEN SATURATION; PROSPECTIVE STUDY; RESPIRATORY EFFORT; RESPIRATORY TRACT PARAMETERS; RESPIRATORY VIRUS; VIRAL BRONCHIOLITIS; WINTER; BLOOD; DECISION SUPPORT SYSTEM; DIAGNOSTIC TEST; NEWBORN; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; UNIVERSITY HOSPITAL; VIRUS DISEASES;

BIOLOGICAL MARKERS; BRONCHIOLITIS; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUCIN-1; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VIRUS DISEASES;

EID: 84908216972     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23850     Document Type: Article

References (45)

1. Abu-Harb M, Bell F, Finn A, Rao WH, Nixon L, Shale D, Everard ML. 1999. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur Respir J 14:139-143.
2. ANAES. Consensus conference: Management of bronchiolitis in infants. September 21, 2000. Available on: http://www.has-sante.fr.
3. Bern RA, Domachowske JB, Rosenberg HF. 2011. Animals models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol 301:148-156.
4. Collins PL, Melero JA. 2011. Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years. Virus Res 162:80-99.
5. Corneli HM, Zorc JJ, Holubkov R, Bregstein JS, Brown KM, Mahajan P, Kuppermann N. Bronchiolitis Study Group for the Pediatric Emergency Applied Research Network. 2012. Bronchiolitis: Clinical characteristics associated with hospitalization and length of stay. Pediatr Emerg Care 28:99-103.
6. Feuillet F, Lina B, Rosa-Calatrava M, Boivin G. 2012. Ten years of human metapneumovirus research. J Clin Virol 53:97-105.
7. Garcia C, Bhore R, Soriano-Fallas A, Trost M, Chason R, Ramilo O, Mejias A. 2010. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 126: e1453-e1460.
8. Garcia C, Soriano-Fallas A, Lozano J, Leos N, Gomez AM, Ramilo O, Mejias A. 2012. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis 31:86-88.
9. Gern JE. 2010. The ABCs of rhinoviruses, wheezing and asthma. J Virol 84:7418-7426.
10. Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB. 1999. Respiratory syncytial virus-induced chemokine expression in the lower Airways: Eosinophil recrutment and degranulation. Am J Respir Crit Care Med 159:1918-1924.
11. Henquell C, Mirand A, Deseubis AL, Regagnon C, Archimbaud C, Chambon M, Bailly JL, Gourdon F, Hermet E, Dauphin JB, Labbé A, Peigue-Lafeuille H. 2012. Prospective genotyping of human rhinoviruses in children and adults during the winter of 2009-2010. J Clin Virol 53:280-284.
12. Hirasawa Y, Kohno N, Yokohama A, Inoue I, Abe M, Hiwada K. 1997. KL-6, a human MUCI mucin, is chemotactic for human fibroblast. Am J Respir Cell Miol Biol 17:501-507.
13. Horimasu Y, Hattori N, Ishikawa N, Kawase S, Tanaka S, Yoshioka K, Yokoyama A, Kohno N, Bonella F, Guzman J, Ohshimo S, Costanel U. 2012. Different MUC1 polymorphisms in German and Japanese ethnicities affect serum KL-6 levels. Respir Med 106:1756-1764.
14. Imai T, Takase M, Takeda S, Kougo T. 2002. Serum KL-6 levels in pediatric patients: Reference values for children and levels in pneumonia, asthma, and measles patients. Pediatr Pulmonol 33:135-141.
15. Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D, Durbin JE, Ramilo O, Mejias A, Flano E. 2012. Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J Virol 86:5422-5436.
16. Ishikawa N, Hattoria N, Yokoyama A, Kohno N. 2012. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. Respir Invest 50:3-13.
17. Jartti T, Korppi M. 2011. Rhinovirus-induced bronchiolitis and asthma development. Pediatr Allergy Immunol 22:350-355.
18. Kawasaki Y, Aoyagi Y, Abe Y, Go H, Imamura T, Kaneko M, Ito M, Katayose M, Hashimoto K, Hosoya M. 2009. Serum KL-6 levels as a biomarker of lung injury in respiratory syncytial virus bronchiolitis. J Med Virol 81:2104-2108.
19. Kawase S, Hattori N, Ishikawa N, Horimasu Y, Fujitaka K, Furonaka O, Isobe T, Miyoshi S, Hamade H, Yamane T, Yokohama A, Kohno N. 2011. Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease. Respir Res 12:97.
20. Kennedy JL, Turner RB, Braciale T, Heymann PW, Borish L. 2012. Pathogenesis of rhinovirus infection. Curr Opin Virol 2:287-293.
21. Kieninger E, Regamey N. 2012. Rhinoviruses: Markers of, or causative for, recurrent wheeze and asthma? Eur Respir J 39:238-239.
22. Kim DH, Kim HS, Shim SY, Lee JA, Choi CW, Kim EK, Kim BI, Choi JH. 2008. Cord blood KL-6, a specific lung injury marker, correlates with the subsequent development and severity of atypical bronchopulmonary dysplasia. Neonatology 93:223-229.
23. Kim CK, Choi J, Kim HB, Shin BM, Kim JT, Fujiwasa T, Koh YY. 2010. A randomized intervention of montelukast for postbronchiolitis: Effect on eosinophil degranulation. J Pediatr 156: 749-754.
24. Kobayashi J, Kitamura S. 1995. KL-6: A serum marker for interstitial pneumonia. Chest 108:311-315.
25. Kobayashi I, Ono S, Kawamura N, Okano M, Miyazawa K, Shibuya H, Kobayashi K. 2001. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis. J Pediatr 138:274-276.
26. Kondo T, Hattori N, Ishikawa N, Murai H, Haruta Y, Hirohashi N, Tanigawa K, Kohno N. 2011. KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome. Respir Res 12:32.
27. Koponen P, Helminen M, Paassilta M, Luukkaala T, Korppi M. 2012. Preschool asthma after bronchiolitis in infancy. Eur Respir J 39:76-80.
28. Kratzer E, Tian Y, Sarich N, Wu T, Meliton A, LeffA, Birukova AA. 2012. Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization. Am J Respir Cell Mol Biol 47:688-697.
29. Marguet C, Lubrano M, Guedin M, Leroux P, Deschildre A, Forget C, Couderc L, Siret D, Donnou MD, Bubenheim M, Vabret A, Freymuth F. 2009. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS ONE 4: e4596.
30. Midulla F, Pierangeli A, Cangiono G, Bonci E, Salvadei S, Scagnolari C, Moretti C, Antonelli G, Ferro V, PapoffP. 2012. Rhinovirus bronchiolitis and recurrent wheezing: 1-year followup. Eur Respir J 39:396-402.
31. Nathani N, Perkins GD, Tunnicliffe W, Murphy N, Manji M, Thickett DR. 2008. Krebs von Lungen 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome. Crit Care Med 12:R12.
32. Ogihara T, Hirano K, Morinobu T, Ogawa S, Hiroi M, ban R, Ogihara H, Tamai H. 2000. KL-6, a mucinous glycoprotein, as an indicator of chronic lung disease of the newborn. J Pediatr 37:280-282.
33. Ogihara T, Hirano K, Morinobu T, Kim HS, Ogawa S, Hiroi M, Oue S, Ban R, Hira S, Hasegawa M, Yamaoka S, Yasui M. 2006. Plasma KL-6 predicts the development and outcome of bronchopulmonary dysplasia. Pediatr Res 60:613-618.
34. Papadopoulos NG, Papi A, Meyer J, Stanciu LA, Salvi S, Holgate ST, Johnston SL. 2001. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 31:1060-1066.
35. Pelletier AJ, Mansbach J, Camargo CA. 2006. Direct medical costs of bronchiolitis hospitalizations in the United States. J Pediatrics 118:2418-2423.
36. Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, Halfhide C, Shears P, Smyth RL, Hart CA. 2005. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 191:382-386.
37. Shtatland ES, Cain E, Barton MB. 2001. The perils of stepwise logistic regression and how to escape using information criteria and the Output Pelivery System. SUGI'26 Proceedings. Available on: http://www2.sas.com.
38. Steyerberg EW, Eijkemans MJC, Harrel FE Jr, Habbema JDF. 2000. Prognostic modelling with logistic regression analysis: A comparison of selection and estimation methods in small data sets. Stat Med 19:1059-1079.
39. Subcommittee on Diagnosis and Management of Bronchiolitis. 2006. Diagnosis and management of bronchiolitis. Pediatrics 118:1174-1703.
40. Thorburn K, Harigopal S, Reddy V, Taylor N, van Saene HKF. 2006. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 61:611-615.
41. Tsuji K, Yamamoto S, Ou W, Nishi N, Kobayashi I, Zaitsu M, Muro E, Sadakane Y, Ichimaru T, Hamasaki Y. 2005. dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells. Eur Respir J 26:795-803.
42. Valkonen H, Waris M, Ruohola A, Ruuskanen O, Heikkinen T. 2009. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: A 3-year follow-up. Allergy 64:1359-1365.
43. Wainwright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D, Moloney S, Kimberley A, Woolfield N, Cadzow S, Fiumara F, Wilson P, Mego S, Van deVelde D, Sanders S, O'Rourke P, Francis P. 2003. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 349:27-35.
44. Wang SZ, Xu H, Wraith A, Bowden JJ, Alpers JH, Forsyth KD. 1998. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. Eur Respir J 12:612-618.
45. Zorc JJ, Hall C. 2010. Bronchiolitis: Recent evidence on diagnosis and management. Pediatrics 125:342-349.